Related Experiment Video

Updated: Jul 3, 2026

A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo
07:56

A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo

Published on: August 28, 2014

12.2K

Advances and Challenges of Tissue Vascular Scaffolds and Supercritical Carbon Dioxide Technology in Cardiovascular

Horng-Ta Tseng1,2,3, Yi-Wen Lin1,4, Shih-Ying Sung5

  • 1Taipei Heart Institute, Taipei Medical University, Taipei, 11031, Taiwan.

Tissue Engineering and Regenerative Medicine
|March 3, 2025
PubMed

Insights

Supercritical carbon dioxide (ScCO2) technology offers a biocompatible and eco-friendly method for creating tissue vascular scaffolds. This approach shows promise for advancing cardiovascular disease treatment and tissue regeneration.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Cardiovascular Engineering

Background:

  • Atherosclerosis necessitates alternative vascular grafts due to limitations with autologous vessels.
  • Decellularized tissue scaffolds offer high biocompatibility for cardiovascular applications.
  • Supercritical carbon dioxide (ScCO2) is increasingly utilized for decellularization.

Purpose of the Study:

  • To review current developments in tissue vascular scaffolds for cardiovascular diseases.
  • To focus on the application and challenges of ScCO2 technology in this field.

Main Methods:

  • A comprehensive literature search was conducted on PubMed.
  • The search included relevant keywords and specific terms up to June 2024.

Main Results:

  • ScCO2 is an effective, eco-friendly agent for decellularization, preserving extracellular matrices (ECMs).
  • ScCO2-derived scaffolds exhibit high biocompatibility and reduced immune response, supporting cell proliferation and tissue regeneration.
  • Applications include decellularizing heart valves and arteries for regenerative medicine.

Conclusions:

  • ScCO2 technology presents advantages such as low cellular toxicity, cost-effectiveness, and ease of manipulation.
  • These characteristics position ScCO2 as a valuable tool for advancing cardiovascular tissue regeneration research.
Abstract

Keywords:
Cardiovascular diseaseSupercritical carbon dioxideTissue vascular scaffolds

More Related Videos

Nondestructive Monitoring of Degradable Scaffold-Based Tissue-Engineered Blood Vessel Development Using Optical Coherence Tomography11:12

Nondestructive Monitoring of Degradable Scaffold-Based Tissue-Engineered Blood Vessel Development Using Optical Coherence Tomography

Published on: October 3, 2018

5.6K
Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds06:14

Expansion of Two-dimension Electrospun Nanofiber Mats into Three-dimension Scaffolds

Published on: January 7, 2019

6.9K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...